(Q41658639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

J Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C O'Morain

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

S99-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Campylobacter pylori and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Pathogenetic role of Campylobacter pyloridis in gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Campylobacter-like organisms in patients with gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori and gastro-oesophageal reflux disease--a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Dyspepsia in England and Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Prevalence of symptoms of dyspepsia in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Do young patients with dyspepsia need investigation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Alternative management strategies for patients with suspected peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Possible role of Helicobacter pylori serology in reducing endoscopy workload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Screening dyspepsia by serology to Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Prospective screening of dyspeptic patients by Helicobacter pylori serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

Helicobacter pyloriInfection and Gastroduodenal Injury by Non-Steroidal Anti-Inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2897%2980021-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(97)80021-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9394769%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference